Watch: Innovation @ Penn Virtual Pitch Session

Posted on June 22, 2020 — Jessica Jones Gupta

Seven startups pitched to the Wharton Alumni Club of Austin and guests at the Innovation @ Penn first virtual pitch session. The startups pitching are companies that were scheduled to appear at SXSW 2020 until the festival was cancelled. The order of pitches: Alphagora Lilu Zero Eyes Pawsitive Prohibix Atlas Simply Good Jars Learn more…

Linnaeus Therapeutics scientific cofounders publish preclinical pancreatic cancer data in cellular and molecular gastroenterology and hepatology

Posted on June 15, 2020 — Jessica Jones Gupta

Linnaeus Therapeutics, a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small molecule oncology therapeutics, announced that its scientific cofounders, Christopher Natale, PhD, Vice President of Research at Linnaeus and Todd Ridky, MD, PhD, Assistant Professor of Dermatology at the Perelman School of Medicine at the University of Pennsylvania, presented their findings…

Meet the 10 early-stage companies in Pennovation Accelerator’s 2020 cohort

Posted on — Jessica Jones Gupta

This year’s startups include two graduates of the Penn I-Corps program, Pawsitive and Percepta. Read more on Philly

Webinar Recording: Turn your engineering idea into a startup

Posted on June 8, 2020 — Jessica Jones Gupta

On Thursday, May 28, Manny Stockman of Osage University Partners presented on the things to consider before you launch a startup and common things venture investors consider before investing in an engineering startup.  Watch the recording below.  

Webinar Recording: Survival Strategies for Startups during COVID-19

Posted on May 31, 2020 — Jessica Jones Gupta

A discussion of how startups, small businesses, and entrepreneurs can successfully navigate the challenging times of the coronavirus pandemic. Featuring: – Brett Topche, Managing Director, Red & Blue Ventures Andrew Hamilton, Partner, Morgan, Lewis & Bockius LLP Laurie Actman of the Penn Center for Innovation  

Gene Therapy Program at Penn Medicine joins AAVCOVID Vaccine Project

Posted on — Jessica Jones Gupta

Renowned program led by James M. Wilson, MD, PhD, a leading expert in the technology platform used in the experimental vaccine, to conduct preclinical studies in joint research and development project with Massachusetts Eye and Ear and Massachusetts General Hospital. Read Penn Medicine News

Novartis inks deal to make experimental coronavirus vaccine

Posted on — Jessica Jones Gupta

Swiss drugmaker will make gene-based Covid-19 vaccine being developed at Massachusetts Eye and Ear, Massachusetts General Hospital and University of Pennsylvania. Read more in the Wall Street Journal

Philadelphia biotech company expands successful partnership with Penn

Posted on — Jessica Jones Gupta

Cabaletta Bio is expanding its sponsored research agreement with Penn to include three additional B cell-mediated autoimmune disease targets. The research will be conducted under the direction of Cabaletta co-founder Dr. Aimee Payne, an associate professor of dermatology in Penn’s Perelman School of Medicine and director of the Penn Clinical Autoimmunity Center of Excellence. Read More…

Prescient Therapeutics locks in two licences for new cell therapy tech

Posted on May 27, 2020 — Jessica Jones Gupta

Anti-cancer biotech company Prescient Therapeutics (PTX) has received two key licences to build a new cell therapy platform. Prescient revealed today it has received an exclusive licence from the University of Pennsylvania for a universal immune cell receptor technology platform invented at the university. Read more on The Market Herald

An interview with Nikil Ragav of InventXYZ on I-Corps and the President’s Innovation Prize.

Posted on — Jessica Jones Gupta

Nikil Ragav’s senior year at Penn was an exciting one. It started with him taking the I-Corps course in the fall,  leveraging that experience and expanding his startup over winter, to then winning the President’s Innovation Prize in the spring. Only a few weeks after winning the Innovation Prize, Nikil was a guest speaker in…